Category: Vaccine Headlines
Rare Links Between COVID Vaccines and Adverse Events Studied
MedpageToday Two Yale University researchers want to understand why symptoms that emerge rarely after COVID-19 vaccines occur. Persistent symptoms after vaccination — sometimes called “long vax” — are similar to those reported with long COVID, including small-fiber neuropathy and postural orthostatic tachycardia syndrome (POTS ). But studies have largely shown that the risk of post-vaccine events do […]
Aug 1, 2023
GSK’s Arexvy to lead new RSV vaccines sales race with Moderna a close second: report
Fierce Pharma We waited years for working RSV vaccines and in 2023, in the space of just a few weeks, we had two come all at once, with another on the horizon and a fresh approval for an RSV prevention med. But how will the RSV market shake out? Well, the analysts at GlobalData crunched […]
Jul 25, 2023
Preparing for the next pandemic before it starts
NIH In March 2020, the world changed in the blink of an eye as countries around the world locked down to slow the spread of COVID-19. This often deadly disease, caused by a previously unknown coronavirus called SARS-CoV-2, seeded outbreaks across the globe in record time. By the end of 2022, it had killed more […]
Jul 25, 2023
After a historic downturn due to the pandemic, childhood immunizations are improving
NPR Fewer children around the world missed receiving routine vaccinations in 2022 compared to the year before, indicating a rebound in childhood immunizations following the COVID-19 pandemic, according to new statistics released by the World Health Organization and UNICEF. Last year, 20.5 million children did not get one or more rounds of the DTaP (diphtheria, […]
Jul 18, 2023
COVID-19 Vaccines Saved Dementia Patients’ Lives in Nursing Homes
UCSF Deaths among older adults with dementia fell starkly in nursing homes and long-term care centers after COVID-19 vaccinations became available, yet remained high for those living at home, according to a new study led by UC San Francisco. The nationwide study published July 17, 2023 in JAMA Neurology, is the first to use data from […]
Jul 18, 2023
HHS CDC Recommendation Follows the Advisory Committee on Immunization Practices’ (ACIP) Recommendations for the Use of New GSK and Pfizer RSV Vaccines for People Ages 60 Years and Older Today, in response to the Centers for Disease Control and Prevention’s (CDC) recommendation of the Respiratory Syncytial Virus (RSV) vaccine for seniors over 60, U.S. Department of […]
Jul 5, 2023
JAMA On June 15, members of the US Food and Drug Administration’s (FDA) Vaccine and Related Biological Products Advisory Committee (VRBPAC) voted unanimously to recommend updating the COVID-19 vaccine composition to a monovalent XBB lineage. On June 16, the FDA announced that it had advised manufacturers planning to update their COVID-19 vaccines that they should specifically target XBB.1.5. Scientists […]
Jul 5, 2023
New scheme aims to get vaccines to outbreaks faster
Reuters Three global health bodies are teaming up to investigate stockpiling experimental vaccines for rare infectious diseases so the shots can be tested more quickly when outbreaks happen, a top official from vaccine alliance Gavi told Reuters. The initiative will be led by Gavi, the World Health Organization (WHO) and the Coalition for Epidemic Preparedness […]
Jun 27, 2023
FDA asks drugmakers to update Covid boosters to target XBB.1.5 for the fall
NBC The updated shots are expected to be distributed as early as September as part of a fall booster campaign. The Food and Drug Administration said Friday that it was advising drugmakers to update the Covid booster shots to target XBB.1.5, the predominant coronavirus strain in the United States. The announcement came a day after an advisory […]
Jun 20, 2023
Pfizer, Moderna and Novavax gear up for fall Covid vaccine rollout with an important head start
MSNBC The U.S. Food and Drug Administration’s Covid strain selection for the next round of shots puts Pfizer, Moderna and Novavax on track to deliver new jabs in time for the fall – a decisive win for the vaccine makers as they gear up to compete against one another. The FDA on Friday advised the three companies to manufacture single-strain jabs targeting the omicron subvariant XBB.1.5, one of the […]
Jun 20, 2023